Ya-Hui Huang Selected Research

Thyroid Hormone Receptors (Thyroid Hormone Receptor)

12/2016	Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.
1/2016	Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
6/2015	Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
9/2013	Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
4/2013	Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
3/2012	Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
6/2010	Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines.
3/2008	Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
5/2006	Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Hui Huang Research Topics

Disease

33	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 06/2004
33	Neoplasms (Cancer) 05/2022 - 03/2008
10	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2008
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2007
3	Liver Neoplasms (Liver Cancer) 10/2021 - 01/2012
3	Hypotension (Low Blood Pressure) 07/2021 - 01/2018
3	Hepatitis C 04/2021 - 01/2017
2	Infections 05/2022 - 01/2017
2	Hepatitis B 05/2022 - 01/2020
2	Stroke (Strokes) 07/2021 - 06/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 10/2003
2	Carcinogenesis 12/2018 - 08/2009
2	Carcinoma (Carcinomatosis) 01/2012 - 01/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2011 - 01/2011
1	Chronic Hepatitis B 05/2022
1	Circulating Neoplastic Cells 05/2022
1	Albuminuria 04/2022
1	Cerebral Infarction 07/2021
1	Hypertension (High Blood Pressure) 06/2021
1	Virus Diseases (Viral Diseases) 04/2021
1	Hypercapnia 01/2021
1	Respiratory Acidosis 01/2021
1	Hypoventilation 01/2021
1	Sarcopenia 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2019
1	Diarrhea 04/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Necrosis 01/2019
1	Pain (Aches) 01/2018
1	AIDS-Related Complex (ARC) 01/2018
1	Liver Failure 01/2017
1	Hepatitis 01/2017

Drug/Important Bio-Agent (IBA)

13	Thyroid HormonesIBA 12/2018 - 02/2006
12	Proteins (Proteins, Gene)FDA Link 12/2019 - 09/2002
9	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 12/2016 - 05/2006
6	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2012
5	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020 - 10/2004
4	Complementary DNA (cDNA)IBA 10/2008 - 06/2004
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2011
3	CateninsIBA 08/2014 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 01/2011 - 01/2007
2	Pharmaceutical PreparationsIBA 05/2022 - 03/2008
2	Oxygen (Dioxygen)IBA 07/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2019 - 12/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2008
2	FurinIBA 01/2012 - 08/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2008 - 02/2006
1	Telbivudine FDA Link 05/2022
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	LipidsIBA 04/2022
1	Biological ProductsIBA 01/2022
1	CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)IBA 01/2022
1	CytidineIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 07/2021
1	MT-1207IBA 06/2021
1	Interleukin-17 (Interleukin 17)IBA 04/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2020
1	entecavir FDA Link 12/2020
1	Lamivudine (Epivir)FDA Link 12/2020
1	MevinphosIBA 10/2020
1	Superoxides (Superoxide)IBA 10/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	hepatitis B virus X proteinIBA 01/2020
1	aci-reductone oxidase (CO-forming)IBA 11/2019
1	Pemetrexed (MTA)FDA Link 11/2019
1	5'-methylthioadenosineIBA 11/2019
1	S-Adenosylmethionine (Ademetionine)IBA 11/2019
1	Methionine (L-Methionine)FDA Link 11/2019
1	Senna ExtractIBA 04/2019
1	TeaIBA 04/2019
1	CadmiumIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 10/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	NociceptinIBA 01/2018
1	SurvivinIBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Chaperonin 60IBA 01/2018
1	HexokinaseIBA 01/2018
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2018
1	Taurine FDA Link 01/2018
1	Untranslated RNA (Noncoding RNA)IBA 11/2017
1	Circulating MicroRNAIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	AlbuminsIBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	StathminIBA 12/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 05/2022 - 07/2014
2	Therapeutics 01/2022 - 01/2016
1	Spinal Anesthesia 07/2021
1	Intravenous Administration 10/2020
1	Subcutaneous Injections 01/2018
1	Hepatectomy 01/2017